Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
CC transcript
Inv. presentation
Credit agrmnt [a]
Acq. announced
Director departure
Appointed director
Employment agrmnt
AMAG PHARMACEUTICALS, INC. (AMAG) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/06/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
03/04/2020 8-K Quarterly results
11/01/2019 8-K Quarterly results
08/07/2019 8-K Investor presentation, Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Promoted products achieved sequential and year-over-year revenue and market share growth 2019 financial guidance lowered: exiting Makena intramuscular market and removing milestone revenue Vyleesi on-track for national launch in September Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
05/07/2019 8-K Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Achieved record Feraheme revenue growth and more than 50% market share for Makena auto-injector Completed integration of Perosphere Pharmaceuticals Inc. and progressed ciraparantag clinical program Reaffirms 2019 financial guidance Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
02/07/2019 8-K Quarterly results
11/01/2018 8-K Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Achieved strong third quarter financial performance and increased full year 2018 guidance Acquired AMAG-423 for severe preeclampsia, reaffirming the company's focus on delivering innovative therapies that address unmet medical needs Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
08/02/2018 8-K Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Achieved 12% revenue growth and record quarterly sales Raising full year revenue and adjusted EBITDA guidance for pharmaceutical products Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
05/03/2018 8-K Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RAISES FULL YEAR FINANCIAL GUIDANCE Strong first quarter execution with two FDA approvals and submission of a new drug application Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
02/27/2018 8-K Quarterly results
Docs: "AMAG Reports 2017 Financial Results and Company Update 2017 GAAP Revenue Increased 15% Year-over-Year February 2018: Company Secures Two U.S. Food and Drug Administration Approvals Conference Call Scheduled for 8:00 a.m. ET Today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
11/02/2017 8-K Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS Intrarosa® launch progressing well with nearly 2,000 prescribing physicians in the first 100 days since launch Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
08/03/2017 8-K Quarterly results
Docs: "AMAG PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Second quarter 2017 GAAP revenue increased 24% over same period last year Intrarosa TM now commercially available Completed Feraheme® submission to FDA to broaden label beyond chronic kidney disease Conference call scheduled for 8:00 a.m. ET today",
"Copy of AMAG Pharmaceuticals, Inc.’s presentation slides"
05/02/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/09/2016 8-K Form 8-K - Current report
05/03/2016 8-K Form 8-K - Current report
02/17/2016 8-K Form 8-K - Current report
11/03/2015 8-K Quarterly results
Docs: "AMAG Pharmaceuticals Reports Third Quarter 2015 Financial Results",
"Copy of presentation slides of the Company during November 3, 2015 conference call"
07/23/2015 8-K Quarterly results
Docs: "AMAG Pharmaceuticals Reports Record Second Quarter 2015 Financial Results",
"Copy of presentation slides of the Company during July 23, 2015 conference call"
05/05/2015 8-K Quarterly results
Docs: "AMAG Pharmaceuticals Reports Record First Quarter 2015 Financial Results and Increases Financial Guidance",
"Copy of presentation slides of the Company during May 5, 2015 conference call"
04/24/2014 8-K Quarterly results
Docs: "AMAG Announces First Quarter 2014 Financial Results",
"Copy of presentation slides of the Company during April 24, 2014 conference call"
02/06/2014 8-K Quarterly results
Docs: "AMAG Provides Business Outlook for 2014 and Reports 2013 Financial Results",
"Copy of presentation slides of the Company for the February 6, 2014 conference call"
04/23/2013 8-K Form 8-K - Current report
03/01/2013 8-K Form 8-K - Current report
05/01/2012 8-K Form 8-K - Current report
04/27/2010 8-K Form 8-K - Current report
04/25/2008 8-K Form 8-K - Current report
07/20/2006 8-K Form 8-K - Current report
07/19/2004 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy